Signifier Medical Technologies Wins Edison Award for Innovative Sleep Apnea Treatment
BOSTON and LONDON – April 20, 2023, Signifier Medical Technologies, a leading medical device company, has been honored with a prestigious Edison Award for its innovative sleep apnea treatment, eXciteOSA®. The Edison Awards, named after Thomas Alva Edison, recognize the most innovative and game-changing products, services, and business leaders across the globe.
eXciteOSA® is the world’s first and only FDA-authorized, clinically proven daytime therapy for mild obstructive sleep apnea (OSA). It is a non-invasive, easy-to-use, and portable solution to help people breathe normally and naturally all night without needing a wearable medical device or a surgical implant. The therapy uses neuromuscular electrical stimulation (NMES) to improve the endurance of the tongue muscles and reduce airway collapse during sleep. This results in a significant reduction in the number of apnea and hypopnea events, and improvements in sleep quality and daytime function.
“We are thrilled to be recognized by the Edison Awards for our groundbreaking work in sleep apnea treatment,” said Akhil Tripathi, CEO of Signifier Medical Technologies. “eXciteOSA® provides a new therapy option for millions of people worldwide who suffer from sleep apnea. Our device offers a non-invasive, effective, and comfortable alternative to traditional sleep apnea treatments.”
The Edison Award is a testament to Signifier Medical Technologies’ commitment to revolutionizing healthcare through innovative solutions that meet the needs of both patients and healthcare professionals alike.
About Signifier Medical Technologies
Signifier is a pioneer in addressing the root causes of sleep-disordered breathing. The Company focuses on developing and commercializing innovative and non-invasive solutions to help restore nighttime breathing – naturally. Founded in 2015, Signifier is at the forefront of sleep therapy, with a mission to develop therapies to improve population health, increase the quality of patients’ healthcare experience, and generate healthcare savings. Signifier has offices in London (UK) and Needham (Massachusetts, USA).
About eXciteOSA®
eXciteOSA is a revolutionary daytime therapy for sleep-disordered breathing. Clinically proven to target a common root cause of OSA, eXciteOSA uses neuromuscular electrical stimulation (NMES) to “exercise” the upper airway muscles, working the intrinsic and extrinsic tongue muscles to improve endurance and prevent airway collapse during sleep. Unlike other devices which are used while patients sleep, eXciteOSA is the first commercially available device used while awake, for just 20 minutes a day.
Signifier is dedicated to engaging with the sleep research community to produce high-quality evidence from rigorous clinical trials. Randomized trials are in progress to understand the potential placebo effect (NCT04974515), the impact of therapy relative to usual care without treatment (NCT05183009; NCT05252156), and the impact of therapy amongst those with moderate OSA (NCT05252156).
For more information, please visit www.signifiermedical.com or www.exciteosa.com.
Contacts
Media:
Jay Cranston
Signifier Medical Technologies Inc
jay.c@signifiermedical.com
Investors and Partners:
Ekin Sezgen
Signifier Medical Technologies Inc
ekin.s@signifiermedical.com
